EVMN Evommune, Inc.
Evommune, Inc. (EVMN) Institutional Ownership
What the institutions did with EVMN last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| EQT Fund Management S.a r.l. | 5.3M | 15.3% |
| RA CAPITAL MANAGEMENT, L.P. | 3.5M | 10.1% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.9M | 5.6% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.9M | 5.6% |
| JPMORGAN CHASE & CO | 1.6M | 4.5% |
| RTW INVESTMENTS, LP | 1.5M | 4.3% |
| Nan Fung Group Holdings Ltd | 1.4M | 4.2% |
| Point72 Asset Management, L.P. | 1.4M | 4.1% |
| ANDERA PARTNERS | 1.4M | 4.0% |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.2M | 3.5% |
| Vestal Point Capital, LP | 1.0M | 2.9% |
| Jupiter Topco LLC | 896.7K | 2.6% |
| BlackRock, Inc. | 886.5K | 2.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 881.9K | 2.5% |
| BAKER BROS. ADVISORS LP | 847.4K | 2.4% |
| Defilade Capital Management, L.P. | 793.1K | 2.3% |
| AMERICAN CENTURY COMPANIES INC | 755.0K | 2.2% |
| Alyeska Investment Group, L.P. | 704.4K | 2.0% |
| Balyasny Asset Management L.P. | 457.0K | 1.3% |
| Velan Capital Investment Management LP | 451.3K | 1.3% |
| UBS Group AG | 413.6K | 1.2% |
| FEDERATED HERMES, INC. | 325.0K | 0.9% |
| GREAT POINT PARTNERS LLC | 325.0K | 0.9% |
| Freestone Grove Partners LP | 306.3K | 0.9% |
| GEODE CAPITAL MANAGEMENT, LLC | 301.8K | 0.9% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| MPM BIOIMPACT LLC | Sold Out | 1.5M | 0 | -1.5M |
| Point72 Asset Management, L.P. | Increased | 36.6K | 1.4M | +1.4M |
| Vestal Point Capital, LP | New | 0 | 1.0M | +1.0M |
| MARSHALL WACE, LLP | Sold Out | 879.7K | 0 | -879.7K |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 1.1M | 1.9M | +821.9K |
| Kynam Capital Management, LP | Sold Out | 625.5K | 0 | -625.5K |
| SECTORAL ASSET MANAGEMENT INC | Sold Out | 589.0K | 0 | -589.0K |
| Verition Fund Management LLC | Reduced | 550.0K | 43.9K | -506.1K |
| ANDERA PARTNERS | Reduced | 1.9M | 1.4M | -505.4K |
| Balyasny Asset Management L.P. | New | 0 | 457.0K | +457.0K |
| PERCEPTIVE ADVISORS LLC | Sold Out | 448.4K | 0 | -448.4K |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 455.1K | 881.9K | +426.8K |
| STEMPOINT CAPITAL LP | Sold Out | 387.6K | 0 | -387.6K |
| EQT Fund Management S.a r.l. | Increased | 4.9M | 5.3M | +358.7K |
| MORGAN STANLEY | Increased | 25.1K | 290.2K | +265.1K |
| AMERICAN CENTURY COMPANIES INC | Increased | 492.9K | 755.0K | +262.1K |
| E Fund Management Co., Ltd. | Sold Out | 243.7K | 0 | -243.7K |
| JANE STREET GROUP, LLC | New | 0 | 232.4K | +232.4K |
| Integral Health Asset Management, LLC | Sold Out | 225.0K | 0 | -225.0K |
| BlackRock, Inc. | Increased | 673.6K | 886.5K | +213.0K |
| Monashee Investment Management LLC | Sold Out | 179.3K | 0 | -179.3K |
| BARCLAYS PLC | Increased | 2.0K | 178.7K | +176.8K |
| ORBIMED ADVISORS LLC | New | 0 | 161.0K | +161.0K |
| Octagon Capital Advisors LP | Sold Out | 143.5K | 0 | -143.5K |
| BNP PARIBAS FINANCIAL MARKETS | Increased | 2.2K | 133.4K | +131.2K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.